Skip to main content
Clinical Trials/ACTRN12605000551695
ACTRN12605000551695
Recruiting
Phase 3

A comparison of artemisinin combination treatment in the form of Coartem® (artemether-lumefantrine) with sulfadoxine-pyrimethamine for treatment of uncomplicated malaria in Jhapa District, Nepal

RTI International0 sites120 target enrollmentSeptember 29, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
RTI International
Enrollment
120
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • i) Uncomplicated falciparum or mixed falciparum/vivax infection, ii) Asexual parasite density \>500/ul whole blood, iii) No prior antimalarial therapy within the last 3 months, iv) Temperature \> 37\.5C axillary, v) Absence of sensitivity to SP or chloroquine, vi) Ability to attend follow\-up visits.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials